SEAN CHAN: Open Payments
NPI 1972123743 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 87 payments from 16 companies in 2025. Trend: 2023 $3,178 · 2024 $850 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 37 | $409 |
| Edwards Lifesciences Corporation | 5 | $309 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 19 | $254 |
| PFIZER INC. | 9 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| AltaThera Pharmaceuticals LLC | 1 | $40 |
| Actelion Pharmaceuticals US, Inc. | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| CVRx, Inc. | 3 | $32 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: LEQVIO, LifeVest, PASCAL, SAPIEN 3 Ultra RESILIA, VYNDAQEL, Kerendia, ELIQUIS, Sotalol Hydrochloride.
Industry payments across AZ — which companies pay providers there.
